Wendy Tate

PhD, Pharmaceutical Economics, Policy & Outcomes; Director, Research Ops at Advarra, camper, hiker, lifelong science nerd with a Peloton spin obsession

[Wendy Tate @tatewr]

Having a strategy = more control and power over your systems! Discover how strategic planning can result in long-term success! Join us on May 16th at 1:00 pm ET for an informative webinar with Erick Sperloen and Cassie Hemmann. Register now! https://t.co/DFELflBbUR

[Wendy Tate @tatewr]

#Advarra is still at the #cri2023 conference in Chicago today. I have so enjoyed connecting with our cancer centers and clinical research partners. Thanks for hosting another great conference AACI!

[Wendy Tate @tatewr]

Excited to be at #cri2023 conference representing #Advarra! Come visit our booth and say hi!

[Wendy Tate @tatewr]

It's not too late!! Survey deadline is extended to Friday 5/19! If you haven't yet shared your thoughts on DE&I in clinical research, now is the time. We'll be publishing results later this summer. https://t.co/wST2NYwSxj

[Wendy Tate @tatewr]

Make your voice heard! Have you seen FDA's recent draft guidance on external controls in clinical trials? The agency is accepting comments through May 2. https://t.co/kI8hiHxnV9

[Wendy Tate @tatewr]

Our new eBook, "2023 Trends Impacting Clinical Research" is your guide to staying on top of the latest developments. Don't get left behind in the fast-paced world of clinical research. Download it now! https://t.co/YIOGeRmk0Z

[Wendy Tate @tatewr]

Planning endpoint adjudication for a global clinical trial? Be sure you consider the impact of applicable privacy regulations. Find out more from James Riddle in our blog: https://t.co/6WCSll5C8c

[Wendy Tate @tatewr]

See how one major cancer center who didn’t have internal capabilities to complete eCRF builds utilized Advarra’s EDC Study Design Service, delivering high-quality eCRF builds to research staff. Download the case study to learn more. https://t.co/TSdgyBtvDd

[Wendy Tate @tatewr]

Coverage analysis is a critical part of clinical research and has serious implications if not done correctly. In our latest blog, Jake Meyer outlines steps to determine whether your clinical trial meets the requirements. Access our checklist now. https://t.co/fjopcrLxdU

[Wendy Tate @tatewr]

Sometimes, the hardest thing to figure out is what you don't know. In David's Compliance Today article "Simple Strategies for Identifying Research Compliance Blindspots," he provides helpful and inventive ideas regarding noncompliance and other issues. https://t.co/N7b2wnESrt

[Wendy Tate @tatewr]

Just like research evolves to adapt new practices, so do ethical oversight committees. Read how IRBs continue to innovate to keep pace with the rapid changes and evolution of research conduct. https://t.co/nPREUkJbq7

[Wendy Tate @tatewr]

Join Advarra experts Rob Romanchuk, Erin Odor, and Alethea Wieland for a roundtable discussion on November 15, 2022, discussing diverse perspectives on the latest #FDA guidance for Clinical Decision Software. https://t.co/v77gBCX0jw

[Wendy Tate @tatewr]

Pre-screening is a critical but often overseen component of participant recruitment. Explore the role of technology-enabled pre-screening in our blog: https://t.co/Zxjvs9MMGG

[Wendy Tate @tatewr]

Data-driven decisions are only as powerful as the data informing them! Explore the power of diverse datasets in site selection and planning: https://t.co/pQjCmSy9uN

[Advarra @advarra]

An investigator-initiated trial (IIT) occurs when an investigator creates the idea for a study, develops the protocol, and serves as the sponsor and investigator for the trial.

Download our latest eBook: https://t.co/a43F3P46X5

[Wendy Tate @tatewr]

See how Inova Health System uses Advarra eReg to significantly improve regulatory efficiency and integrate across their technology ecosystem, making life easier for their regulatory staff using eReg's electronic signature workflows. https://t.co/dbP7XdZ2bP

[Wendy Tate @tatewr]

While clinical trial site selection aids in a trial’s success, it’s critical to maximize the study's time, resources, and funds. Read my latest post to learn more! https://t.co/amiTHXQmNa

[Wendy Tate @tatewr]

Endpoint Adjudication Committee (EAC) oversight is important for scientific integrity of a clinical trial. Read our recent white paper to see why it is recommended and how they support safe study conduct. #clinicalresearch #endpoint #themoreyouknow https://t.co/mEsWHnh278

[Wendy Tate @tatewr]

Open to sites within Advarra's tech solutions customer community: share ideas, best practices, strategies, and successes at the 2023 Onsemble Conference. Call for Presentations is open. Plus, if selected, you receive free in-person conference registration! https://t.co/vfqNhqLWAe

[Wendy Tate @tatewr]

Check out my latest post discussing eConsent and some of the considerations to make given silence in the existing federal regulations regarding details specific to electronic consent.

#weekendread #clinicalresearch #informedconsent #econsent https://t.co/o3qd6FnQad